By proceeding, you agree to our Terms of Use and Privacy Policy.
I am Chief Business Officer and member of the Executive Committee of Cellectis, a clinical-stage immuno-oncology biotech developing gene-edited allogeneic CAR-T cells, where I lead on program management, strategy and business development.
Talks About #immunooncology #biotech #businessdevelopment
Preferred Locations #NorthAmerica
Advanced Therapies Europe promises to educate and inspire advanced therapies professionals currently working in Europe, as well as those that are looking to enter into the European market.